Genetic variations of NR1I3 and NR2B1 in Asian populations

Drug Metabolism and Pharmacokinetics

Volumn 28, Issue 2, 2013, Pages 169-176

  Chew, Sin Chi ^a,b   Lim, Joanne Siok Liu ^a,b   Singh, Onkar ^a   Wong, Mabel ^a   Lee, Edmund J D ^b   Chowbay, Balram ^a,c  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Asians; CAR; In silico prediction; NR1I3; NR2B1; Pharmacogenetics; Polymorphisms; RXR ; Tag SNPs

Indexed keywords

ALLELE; ARTICLE; ASIAN; CHINESE; COMPUTER ANALYSIS; CONTROLLED STUDY; ETHNICITY; EXON; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC SCREENING; HUMAN; INDIA; INTRON; MALAYSIA; NORMAL HUMAN; NR1I3 GENE; NR2B1 GENE; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PREDICTION; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84876758259     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-12-SC-060     Document Type: Article

References (38)

1. Xu, C., Li, C. and Kong, A.: Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res., 28: 249-268 (2005).
2. Nishimura, M., Naito, S. and Yokoi, T.: Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. Drug Metab. Pharmacokinet., 19: 135-149 (2004).
3. Baes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D. and Moore, D. D.: A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell. Biol., 14: 1544-1552 (1994).
4. Arnold, K. A., Eichelbaum, M. and Burk, O.: Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor. Nucl. Recept., 2: 1-16 (2004).
5. Lamba, J. K., Lamba, V., Yasuda, K., Lin, Y. S., Assem, M., Thompson, E., Strom, S. and Schuetz, E.: Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J. Pharmacol. Exp. Ther., 311: 811-821 (2004).
6. Suino, K., Peng, L., Reynolds, R., Li, Y., Cha, J. Y., Repa, J. J., Kliewer, S. A. and Xu, H.: The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol. Cell, 16: 893-905 (2004).
7. Yoshinari, K., Yoda, N., Toriyabe, T. and Yamazoe, Y.: Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5A-flanking region. Biochem. Pharmacol., 79: 261-269 (2010).
8. Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P. and Negishi, M.: The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem., 274: 6043-6046 (1999).
9. Goodwin, B., Hodgson, E., D'Costa, D. J., Robertson, G. R. and Liddle, C.: Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol. Pharmacol., 62: 359-365 (2002).
10. Sugatani, J., Kojima, H., Ueda, A., Kakizaki, S., Yoshinari, K., Gong, Q., Owens, I., Negishi, M. and Sueyoshi, T.: The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology, 33: 1232-1238 (2001).
11. Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M. and Edwards, P. A.: Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J. Biol. Chem., 277: 2908-2915 (2002).
12. Swales, K. and Negishi, M.: CAR, driving into the future. Mol. Endocrinol., 18: 1589-1598 (2004).
13. Haussler, M. R., Haussler, C. A., Bartik, L., Whitfield, G. K., Hsieh, J. C., Slater, S. and Jurutka, P. W.: Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr. Rev., 66: S98-S112 (2008).
14. Lefebvre, P., Benomar, Y. and Staels, B.: Retinoid X receptors: common heterodimerization partners with distinct functions. Trends Endocrinol. Metab., 21: 676-683 (2010).
15. Chang, T. K., Bandiera, S. M. and Chen, J.: Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels. Drug Metab. Dispos., 31: 7-10 (2003).
16. Finkelstein, D., Lamba, V., Assem, M., Rengelshausen, J., Yasuda, K., Strom, S. and Schuetz, E.: ADME transcriptome in Hispanic versus White donor livers: evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics. Xenobio-tica, 36: 989-1012 (2006).
17. Ikeda, S., Kurose, K., Ozawa, S., Sai, K., Hasegawa, R., Komamura, K., Ueno, K., Kamakura, S., Kitakaze, M., Tomoike, H., Nakajima, T., Matsumoto, K., Saito, H., Goto, Y., Kimura, H., Katoh, M., Sugai, K., Minami, N., Shirao, K., Tamura, T., Yamamoto, N., Minami, H., Ohtsu, A., Yoshida, T., Saijo, N., Saito, Y. and Sawada, J.: Twenty-six novel single nucleotide polymorphisms and their frequencies of the NR1I3 (CAR) gene in a Japanese population. Drug Metab. Pharmacokinet., 18: 413-418 (2003).
18. Barrett, J. C., Fry, B., Maller, J. and Daly, M. J.: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21: 263-265 (2005).
19. Xu, Z., Kaplan, N. L. and Taylor, J. A.: TAGster: efficient selection of LD tag SNPs in single or multiple populations. Bioinformatics, 23: 3254-3255 (2007).
20. Yuan, H. Y., Chiou, J. J., Tseng, W. H., Liu, C. H., Liu, C. K., Lin, Y. J., Wang, H. H., Yao, A., Chen, Y. T. and Hsu, C. N.: FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res., 34: W635-W641 (2006).
21. Ziebarth, J. D., Bhattacharya, A., Chen, A. and Cui, Y.: PolymiRTS Database 2.0: linking polymorphisms in microRNA target sites with human diseases and complex traits. Nucleic Acids Res., 40: D216-D221 (2012).
22. Lytle, J. R., Yario, T. A. and Steitz, J. A.: Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5A UTR as in the 3A UTR. Proc. Natl. Acad. Sci. USA, 104: 9667-9672 (2007).
23. Fang, Z. and Rajewsky, N.: The Impact of miRNA Target Sites in Coding Sequence and in 3A UTR. PLoS ONE, 6: e18067 (2011).
24. Griffiths-Jones, S., Saini, H. K., van Dongen, S. and Enright, A. J.: miRBase: tools for microRNA genomics. Nucleic Acids Res., 36: D154-D158 (2008).
25. International HapMap Consortium: The International HapMap Project. Nature, 426: 789-796 (2003).
26. Urano, T., Usui, T., Shiraki, M., Ouchi, Y. and Inoue, S.: Association of a single nucleotide polymorphism in the constitutive androstane receptor gene with bone mineral density. Geriatr. Gerontol. Int., 9: 235-241 (2009).
27. di Masi, A., Marinis, E. D., Ascenzi, P. and Marino, M.: Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. Mol. Aspects Med., 30: 297-343 (2009).
28. Hor, S. Y., Lee, S. C., Wong, C. I., Lim, Y. W., Lim, R. C., Wang, L. Z., Fan, L., Guo, J. Y., Lee, H. S., Goh, B. C. and Tan, T.: PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients. Pharmacogenomics J., 8: 139-146 (2008).
29. Ikeda, S., Kurose, K., Jinno, H., Sai, K., Ozawa, S., Hasegawa, R., Komamura, K., Kotake, T., Morishita, H., Kamakura, S., Kitakaze, M., Tomoike, H., Tamura, T., Yamamoto, N., Kunitoh, H., Yamada, Y., Ohe, Y., Shimada, Y., Shirao, K., Kubota, K., Minami, H., Ohtsu, A., Yoshida, T., Saijo, N., Saito, Y. and Sawada, J. I.: Functional analysis of four naturally occurring variants of human constitutive androstane receptor. Mol. Genet. Metab., 86: 314-319 (2005).
30. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A. and Evans, R. M.: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature, 345: 224-229 (1990).
31. Karami, S., Brennan, P., Rosenberg, P., Navratilova, M., Mates, D., Zaridze, D., Janout, V., Kollarova, H., Bencko, V., Matveev, V., Szeszenia-Dabrowska, N., Holcatova, I., Yeager, M., Chanock, S., Menashe, I., Rothman, N., Chow, W., Moore, L. and Boffetta, P.: Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk. PLoS ONE, 4: e7013 (2009).
32. Kölsch, H., Lütjohann, D., Jessen, F., Popp, J., Hentschel, F., Kelemen, P., Friedrichs, S., Maier, W. and Heun, R.: RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism. J. Cell. Mol. Med., 13: 589-598 (2009).
33. Egan, J. B., Thompson, P. A., Ashbeck, E. L., Conti, D. V., Duggan, D., Hibler, E., Jurutka, P. W., Leroy, E. C., Martínez, M. E., Mount, D. and Jacobs, E. T.: Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res., 70: 1496-1504 (2010).
34. Lu, Y., Ye, X., Cao, Y., Li, Q., Yu, X., Cheng, J., Gao, Y., Ma, J., Du, W. and Zhou, L.: Genetic Variants in Peroxisome Proliferator-Activated Receptor-£ and Retinoid X Receptor-α Gene and Type 2 Diabetes Risk: A Case-Control Study of a Chinese Han Population. Diabetes Technol. Ther., 13: 157-164 (2011).
35. Wortham, M., Czerwinski, M., He, L., Parkinson, A. and Wan, Y. J. Y.: Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab. Dispos., 35: 1700-1710 (2007).
36. Lal, S., Wong, Z. W., Sandanaraj, E., Xiang, X., Ang, P. C. S., Lee, E. J. D. and Chowbay, B.: Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients. Cancer Sci., 99: 816-823 (2008).
37. Chew, S. C., Singh, O., Chen, X., Ramasamy, R. D., Kulkarni, T., Lee, E. J. D., Tan, E. H., Lim, W. T. and Chowbay, B.: The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmaco-dynamics of docetaxel in nasopharyngeal carcinoma patients. Cancer Chemother. Pharmacol., 67: 1471-1478 (2011).
38. Sandanaraj, E., Lal, S., Selvarajan, V., Ooi, L. L., Wong, Z. W., Wong, N. S., Ang, P. C. S., Lee, E. J. D. and Chowbay, B.: PXR pharmaco-genetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients. Clin. Cancer Res., 14: 7116-7126 (2008).